Frankfurt - Delayed Quote EUR

Mersana Therapeutics, Inc. (0M4.F)

0.2711
-0.0060
(-2.17%)
As of 8:01:16 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
34,006
40,497
36,855
26,581
43
Operating Expense
110,853
113,833
207,812
230,348
168,901
Operating Income
-76,847
-73,336
-170,957
-203,767
-168,858
Net Non Operating Interest Income Expense
3,256
4,562
8,000
-445
-1,202
Other Income Expense
--
--
-8,713
--
--
Pretax Income
-73,591
-68,774
-171,670
-204,212
-170,060
Tax Provision
--
418
0
0
--
Net Income Common Stockholders
-74,009
-69,192
-171,670
-204,212
-170,060
Diluted NI Available to Com Stockholders
-74,009
-69,192
-171,670
-204,212
-170,060
Basic EPS
-0.59
-0.56
-1.48
-2.18
-2.41
Diluted EPS
-0.59
-0.56
-1.48
-2.18
-2.41
Basic Average Shares
123,299.8880
122,539.5980
116,112.8910
93,654.2430
70,580.9490
Diluted Average Shares
123,299.8880
122,539.5980
116,112.8910
93,654.2430
70,580.9490
Total Expenses
110,853
113,833
207,812
230,348
168,901
Net Income from Continuing & Discontinued Operation
-74,009
-69,192
-171,670
-204,212
-170,060
Normalized Income
-74,009
-69,192
-162,957
-204,212
-170,060
Interest Income
6,903
8,436
12,073
2,883
65
Interest Expense
3,647
3,874
4,073
3,328
1,267
Net Interest Income
3,256
4,562
8,000
-445
-1,202
EBIT
-69,944
-64,900
-167,597
-200,884
-168,793
EBITDA
-68,423
-63,272
-166,080
-199,957
-167,938
Reconciled Depreciation
1,521
1,628
1,517
927
855
Net Income from Continuing Operation Net Minority Interest
-74,009
-69,192
-171,670
-204,212
-170,060
Total Unusual Items Excluding Goodwill
0
0
-8,713
0
0
Total Unusual Items
0
0
-8,713
0
0
Normalized EBITDA
-68,423
-63,272
-157,367
-199,957
-167,938
Tax Rate for Calcs
0
0.0002
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/4/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

25I.SG ImmuPharma PLC
0.0250
+19.05%
 
GXE.F Galapagos NV
25.12
-0.48%
 
IMR.BE AC Immune SA
1.4540
0.00%
 
BCX.WA Bioceltix S.A.
101.60
-2.68%
 
2LB.MU Iovance Biotherapeutics Inc
1.5420
0.00%
 
8EM.BE Editas Medicine Inc
1.4920
+2.72%
 
22Z.SG Zealand Pharma A/S
59.92
-0.20%
 
9WV.BE Nutriband Inc
6.90
+21.05%
 
ATOS.MX Atossa Therapeutics, Inc.
16.00
0.00%
 
RXK3.MU SELLAS Life Sciences Group Inc
1.3930
-5.04%